Ionis announces GSK has advanced bepirovirsen into Phase 3 development
Drugs.com,
CARLSBAD, Calif., Feb. 1, 2023. Ionis Pharmaceuticals, Inc. today announced that GSK has initiated two randomized, double-blind…
CARLSBAD, Calif., Feb. 1, 2023. Ionis Pharmaceuticals, Inc. today announced that GSK has initiated two randomized, double-blind…
Initiation of the Phase 3 program expands Ionis’ late-stage pipeline to 7 medicines in 9 indications CARLSBAD, Calif., Feb.
Initiation of the Phase 3 program expands Ionis' late-stage pipeline to 7 medicines in 9 indications CARLSBAD, Calif., Feb.
Initiation of the Phase 3 program expands Ionis' late-stage pipeline to 7 medicines in 9 indications CARLSBAD, Calif., Feb.